Vinblastine and antihelmintic mebendazole potentiate temozolomide in resistant gliomas
出版年份 2017 全文链接
标题
Vinblastine and antihelmintic mebendazole potentiate temozolomide in resistant gliomas
作者
关键词
Glioblastoma, Temozolomide, Vinblastine, Mebendazole, Long-term analysis
出版物
INVESTIGATIONAL NEW DRUGS
Volume 36, Issue 2, Pages 323-331
出版商
Springer Nature
发表日期
2017-08-29
DOI
10.1007/s10637-017-0503-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- p21: A Two-Faced Genome Guardian
- (2017) Alexandros G. Georgakilas et al. TRENDS IN MOLECULAR MEDICINE
- The regrowth kinetic of the surviving population is independent of acute and chronic responses to temozolomide in glioblastoma cell lines
- (2016) Andrew Oliveira Silva et al. EXPERIMENTAL CELL RESEARCH
- Drug repurposing for glioblastoma based on molecular subtypes
- (2016) Yang Chen et al. JOURNAL OF BIOMEDICAL INFORMATICS
- Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma
- (2016) Caroline Happold et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
- (2016) Jan C. Buckner et al. NEW ENGLAND JOURNAL OF MEDICINE
- A guide for the analysis of long-term population growth in cancer
- (2016) Andrew O. Silva et al. TUMOR BIOLOGY
- Notch3 overexpression causes arrest of cell cycle progression by inducing Cdh1 expression in human breast cancer cells
- (2015) Chun-Fa Chen et al. CELL CYCLE
- Drug Delivery Systems and Combination Therapy by Using Vinca Alkaloids
- (2015) Chun-Ting Lee et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Novel chemotherapeutics and other therapies for treating high-grade glioma
- (2015) Jennifer H Kang et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterization of novel markers of senescence and their prognostic potential in cancer
- (2014) M Althubiti et al. Cell Death & Disease
- Notch3 Functions as a Tumor Suppressor by Controlling Cellular Senescence
- (2013) H. Cui et al. CANCER RESEARCH
- Ionizing radiation-induced gene expression changes in TP53 proficient and deficient glioblastoma cell lines
- (2013) P.R.D.V. Godoy et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/ -catenin pathway
- (2013) C. Riganti et al. NEURO-ONCOLOGY
- XIAP downregulation accompanies mebendazole growth inhibition in melanoma xenografts
- (2012) Nicole A. Doudican et al. ANTI-CANCER DRUGS
- Phase II Study of Weekly Vinblastine in Recurrent or Refractory Pediatric Low-Grade Glioma
- (2012) Eric Bouffet et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
- (2012) Gregory Cairncross et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
- (2012) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Nuclear Morphometric Analysis (NMA): Screening of Senescence, Apoptosis and Nuclear Irregularities
- (2012) Eduardo C. Filippi-Chiela et al. PLoS One
- A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study
- (2011) Katherine E. Warren et al. JOURNAL OF NEURO-ONCOLOGY
- Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme
- (2011) Ren-Yuan Bai et al. NEURO-ONCOLOGY
- Molecular targeting of glioblastoma: Drug discovery and therapies
- (2011) Ren-Yuan Bai et al. TRENDS IN MOLECULAR MEDICINE
- The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma
- (2010) P. A. Spagnuolo et al. BLOOD
- Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma
- (2010) Michael Brada et al. JOURNAL OF CLINICAL ONCOLOGY
- NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
- (2009) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Mebendazole Induces Apoptosis via Bcl-2 Inactivation in Chemoresistant Melanoma Cells
- (2008) N. Doudican et al. MOLECULAR CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started